News
InvestorsHub on MSN32m
Cognition Therapeutics Shares Surge After FDA Confirms Phase 3 Trial Design
Cognition Therapeutics Inc (NASDAQ:CGTX) saw its stock jump 27% following FDA confirmation that the company’s proposed Phase ...
In its campaign against “woke” science, the Trump administration has closed down studies and programs focused on the gaps between racial and socioeconomic groups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback